IOL Chemicals & Pharmaceuticals announced that the European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for Company's API product 'Sitagliptin Phosphate Monohydrate' on 27 October 2025. Sitagliptin Phosphate Monohydrate is an oral antidiabetic medication used to control high blood sugar levels.

Powered by Capital Market - Live News